Antidepressants and body weight: a comprehensive review and meta-analysis
- PMID: 21062615
- DOI: 10.4088/JCP.09r05346blu
Antidepressants and body weight: a comprehensive review and meta-analysis
Abstract
Objective: Psychotropic drugs often induce weight gain, leading to discomfort and discontinuation of treatment and, more importantly, increasing the risk of obesity-related illnesses such as diabetes mellitus, hypertension, and coronary heart disease. There is evidence that antidepressant drugs may induce a variable amount of weight gain, but results are sparse and often contradictory.
Data sources: We performed a literature search using the MEDLINE, ISI Web of Knowledge, and Cochrane research databases for all publications available to January 2009. We used the following keywords: antidepressant, psychotropic drugs, body weight, weight gain, obesity, overweight, adverse event, side effects, SSRIs, tricyclic antidepressants, and the name of each antidepressant active compound together with body weight or other keywords. Studies reporting body weight changes during treatment with different antidepressants were selected for eligibility. Finally, 116 studies were included in the analysis.
Data extraction: Weight change mean and standard deviation and size of each group were recorded. Missing means and standard deviations were directly calculated by using information available in the article when possible. Non-placebo-controlled studies were compared to a virtual placebo sample, whose mean and standard deviation were derived by the weighted mean of means and standard deviations of all placebo samples. Methodological quality of studies, heterogeneity, publication bias, and effect of treatment duration were systematically controlled.
Data synthesis: Quantitative results evidenced that amitriptyline, mirtazapine, and paroxetine were associated with a greater risk of weight gain. In contrast, some weight loss occurs with fluoxetine and bupropion, although the effect of fluoxetine appears to be limited to the acute phase of treatment. Other compounds have no transient or negligible effect on body weight in the short term. However, the effect of each antidepressant may vary greatly depending on an individual's characteristics and generally became more evident in the long term to a variable degree across compounds.
Conclusions: Despite the fact that some analyses were done on only a few studies due to the difficulty of finding reliable information in literature, to our knowledge, this is the first comprehensive meta-analysis to allow comparison of different antidepressants as regards their impact on body weight. Data presented may be helpful for a more accurate treatment selection in patients at risk of obesity or related medical illness.
© Copyright 2010 Physicians Postgraduate Press, Inc.
Similar articles
-
Psychiatric medication-induced obesity: a review.Obes Rev. 2004 May;5(2):115-21. doi: 10.1111/j.1467-789X.2004.00139.x. Obes Rev. 2004. PMID: 15086865 Review.
-
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.J Clin Psychiatry. 2001 Apr;62(4):256-60. J Clin Psychiatry. 2001. PMID: 11379839
-
Weight gain in the treatment of mood disorders.J Clin Psychiatry. 2003;64 Suppl 8:22-9. J Clin Psychiatry. 2003. PMID: 12892538 Review.
-
Attitudes about antidepressants: influence of information about weight-related side effects.Percept Mot Skills. 2000 Apr;90(2):453-6. doi: 10.2466/pms.2000.90.2.453. Percept Mot Skills. 2000. PMID: 10833739 Clinical Trial.
-
[H2 receptor blockaders and weight control].Lakartidningen. 2000 Jul 12;97(28-29):3299. Lakartidningen. 2000. PMID: 10997029 Swedish. No abstract available.
Cited by 146 articles
-
Uncovering the Potential Mechanisms of Coptis chinensis Franch. for Serious Mental Illness by Network Pharmacology and Pharmacology-Based Analysis.Drug Des Devel Ther. 2022 Feb 9;16:325-342. doi: 10.2147/DDDT.S342028. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35173416 Free PMC article.
-
Psychotropic Medications in Metabolic and Bariatric Surgery: Research Updates and Clinical Considerations.Curr Psychiatry Rep. 2022 Jan;24(1):89-98. doi: 10.1007/s11920-022-01317-4. Epub 2022 Jan 25. Curr Psychiatry Rep. 2022. PMID: 35076886 Review.
-
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.Psychopharmacol Bull. 2021 Nov 3;51(4):8-30. Psychopharmacol Bull. 2021. PMID: 34887596
-
Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women.J Pers Med. 2021 Oct 26;11(11):1096. doi: 10.3390/jpm11111096. J Pers Med. 2021. PMID: 34834448 Free PMC article.
-
Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing.Ment Health Clin. 2021 Nov 8;11(6):320-333. doi: 10.9740/mhc.2021.11.320. eCollection 2021 Nov. Ment Health Clin. 2021. PMID: 34824957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical